(STN) Stantec - Overview
Stock: Infrastructure, Environmental Services, Architecture, Engineering, Planning
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.66% |
| Yield on Cost 5y | 1.73% |
| Yield CAGR 5y | -1.71% |
| Payout Consistency | 96.7% |
| Payout Ratio | 15.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.2% |
| Relative Tail Risk | -7.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.07 |
| Alpha | 21.08 |
| Character TTM | |
|---|---|
| Beta | 0.741 |
| Beta Downside | 0.630 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.06% |
| CAGR/Max DD | 1.36 |
Description: STN Stantec January 03, 2026
Stantec Inc. (NYSE: STN) is a Canadian-based professional services firm that delivers integrated infrastructure, facilities, and environmental solutions to public- and private-sector clients across North America and internationally.
The company’s portfolio spans the full project lifecycle-evaluation, planning, design, construction administration, commissioning, operation, and de-commissioning-covering water resources, sustainable infrastructure, energy & resources, architecture, interior design, landscape architecture, surveying, and project economics. Its client mix includes residential, logistics, retail, higher education, urban regeneration, science & technology, commercial workplace, and hospitality markets.
Key performance indicators (as of FY 2023) show a revenue run-rate of roughly $5.6 billion, a backlog of $7.3 billion (≈130 % of annual revenue), and an operating margin of ≈ 7.5 %. The firm benefits from macro-drivers such as U.S. and Canadian federal infrastructure stimulus packages (estimated $1.2 trillion in FY 2024-2026 spending) and rising ESG-focused water and climate-resilience projects, which have historically contributed to a 3-5 % annual revenue uplift for firms in the research & consulting services sub-industry.
For deeper quantitative analysis, you might explore ValueRay’s detailed financial models for STN.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 447.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 3.52 > 1.0 |
| NWC/Revenue: 8.31% < 20% (prev 10.78%; Δ -2.47% < -1%) |
| CFO/TA 0.11 > 3% & CFO 857.4m > Net Income 447.6m |
| Net Debt (2.35b) to EBITDA (991.5m): 2.37 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (114.1m) vs 12m ago 0.0% < -2% |
| Gross Margin: 42.34% > 18% (prev 0.43%; Δ 4191 % > 0.5%) |
| Asset Turnover: 99.16% > 50% (prev 103.0%; Δ -3.87% > 0%) |
| Interest Coverage Ratio: 7.18 > 6 (EBITDA TTM 991.5m / Interest Expense TTM 96.3m) |
Altman Z'' 2.48
| A: 0.08 (Total Current Assets 2.92b - Total Current Liabilities 2.30b) / Total Assets 8.12b |
| B: 0.21 (Retained Earnings 1.68b / Total Assets 8.12b) |
| C: 0.09 (EBIT TTM 690.9m / Avg Total Assets 7.53b) |
| D: 0.66 (Book Value of Equity 3.22b / Total Liabilities 4.89b) |
| Altman-Z'' Score: 2.48 = A |
Beneish M -2.98
| DSRI: 1.03 (Receivables 2.46b/2.28b, Revenue 7.47b/7.15b) |
| GMI: 1.01 (GM 42.34% / 42.69%) |
| AQI: 1.05 (AQ_t 0.53 / AQ_t-1 0.51) |
| SGI: 1.04 (Revenue 7.47b / 7.15b) |
| TATA: -0.05 (NI 447.6m - CFO 857.4m) / TA 8.12b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of STN shares?
Over the past week, the price has changed by +2.47%, over one month by +2.19%, over three months by -6.28% and over the past year by +33.70%.
Is STN a buy, sell or hold?
- StrongBuy: 3
- Buy: 7
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the STN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 94.3 | -7.1% |
| Analysts Target Price | 94.3 | -7.1% |
| ValueRay Target Price | 124.8 | 22.9% |
STN Fundamental Data Overview February 03, 2026
P/E Trailing = 32.3791
P/E Forward = 22.9358
P/S = 1.7869
P/B = 4.8493
P/EG = 1.63
Revenue TTM = 7.47b CAD
EBIT TTM = 690.9m CAD
EBITDA TTM = 991.5m CAD
Long Term Debt = 1.70b CAD (from longTermDebt, last quarter)
Short Term Debt = 422.3m CAD (from shortTermDebt, last quarter)
Debt = 2.71b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.35b CAD (from netDebt column, last quarter)
Enterprise Value = 17.79b CAD (15.46b + Debt 2.71b - CCE 382.3m)
Interest Coverage Ratio = 7.18 (Ebit TTM 690.9m / Interest Expense TTM 96.3m)
EV/FCF = 22.10x (Enterprise Value 17.79b / FCF TTM 804.9m)
FCF Yield = 4.52% (FCF TTM 804.9m / Enterprise Value 17.79b)
FCF Margin = 10.78% (FCF TTM 804.9m / Revenue TTM 7.47b)
Net Margin = 5.99% (Net Income TTM 447.6m / Revenue TTM 7.47b)
Gross Margin = 42.34% ((Revenue TTM 7.47b - Cost of Revenue TTM 4.30b) / Revenue TTM)
Gross Margin QoQ = 43.35% (prev 39.96%)
Tobins Q-Ratio = 2.19 (Enterprise Value 17.79b / Total Assets 8.12b)
Interest Expense / Debt = 1.04% (Interest Expense 28.1m / Debt 2.71b)
Taxrate = 24.55% (48.8m / 198.8m)
NOPAT = 521.3m (EBIT 690.9m * (1 - 24.55%))
Current Ratio = 1.27 (Total Current Assets 2.92b / Total Current Liabilities 2.30b)
Debt / Equity = 0.84 (Debt 2.71b / totalStockholderEquity, last quarter 3.23b)
Debt / EBITDA = 2.37 (Net Debt 2.35b / EBITDA 991.5m)
Debt / FCF = 2.92 (Net Debt 2.35b / FCF TTM 804.9m)
Total Stockholder Equity = 3.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.94% (Net Income 447.6m / Total Assets 8.12b)
RoE = 14.61% (Net Income TTM 447.6m / Total Stockholder Equity 3.06b)
RoCE = 14.51% (EBIT 690.9m / Capital Employed (Equity 3.06b + L.T.Debt 1.70b))
RoIC = 11.20% (NOPAT 521.3m / Invested Capital 4.65b)
WACC = 7.48% (E(15.46b)/V(18.17b) * Re(8.65%) + D(2.71b)/V(18.17b) * Rd(1.04%) * (1-Tc(0.25)))
Discount Rate = 8.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.59%
[DCF Debug] Terminal Value 82.98% ; FCFF base≈660.4m ; Y1≈814.7m ; Y5≈1.39b
Fair Price DCF = 209.2 (EV 26.21b - Net Debt 2.35b = Equity 23.86b / Shares 114.1m; r=7.48% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 15.37 | EPS CAGR: -41.47% | SUE: -4.0 | # QB: 0
Revenue Correlation: 86.71 | Revenue CAGR: 24.64% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.32 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=6
EPS next Year (2026-12-31): EPS=6.05 | Chg30d=+0.011 | Revisions Net=-4 | Growth EPS=+15.1% | Growth Revenue=+9.8%